Biotech Series C Investors & VC Firms
623 firms in this list, with a median first check of $1M. 121 of them lead rounds. Generated from verified public data and updated continuously.
Andreessen Horowitz
Menlo ParkSeed–Late Stage$500K – $50M
109 people
New Enterprise Associates (NEA)
Menlo ParkSeed–Late Stage$200K – $40M
67 people
Bessemer Venture Partners
Redwood CitySeed–Late Stage$5M – $100M
56 people
F-Prime Capital
CambridgePre-Seed–Late Stage$3M – $10M
104 people
Khosla Ventures
Menlo ParkPre-Seed–Late Stage$5K – $50M
57 people
Sequoia Capital
Menlo ParkPre-Seed–Late Stage$4.4M – $214M
42 people
OrbiMed
New YorkPre-Seed–Late Stage$1M – $75M
117 people
Norwest Venture Partners
Menlo ParkSeed–Late Stage$10M – $30M
48 people
General Catalyst
San FranciscoPre-Seed–Late Stage$30M
27 people
Kleiner Perkins
Menlo ParkPre-Seed–Late Stage$500K – $15M
38 people
GV (Google Ventures)
Mountain ViewSeed–Late Stage$250K – $50M
54 people
DCVC (Data Collective)
Palo AltoPre-Seed–Late Stage$5M – $25M
47 people
Madrona Venture Group
SeattlePre-Seed–Growth$2M – $10M
69 people
Menlo Ventures
San FranciscoPre-Seed–Growth$1M – $20M
49 people
8VC
AustinPre-Seed–Late Stage$100K – $50M
48 people
Octopus Ventures
LondonPre-Seed–Late Stage$130K – $1.3M
75 people
Gobi Partners
Hong KongPre-Seed–Late Stage$709K – $37M
74 people
Andera Partners
ParisPre-Seed–Late Stage
45 people
Founders Fund
San FranciscoSeed–Late Stage$500K – $5M
33 people
BDC Fund Investments (Fund-of-Funds)
MontréalSeed–Growth
117 people
Foresite Capital
West HollywoodPre-Seed–Late Stage
62 people
Aju IB Invesment Corporation
SeoulSeed–Late Stage
Frazier Life Sciences
Palo AltoSeed–Late Stage
71 people
B Capital Group
Manhattan BeachPre-Seed–Late Stage$10M – $50M
42 people
Frequently asked questions
- Who are the top biotech series c investors & vc firms?
- Top biotech series c investors & vc firms include Andreessen Horowitz, New Enterprise Associates (NEA), Bessemer Venture Partners, F-Prime Capital, Khosla Ventures, Sequoia Capital, OrbiMed, Norwest Venture Partners — 623 firms in total meet the criteria.
- What is the typical first check among biotech series c investors & vc firms?
- The median first check among the 623 biotech series c investors & vc firms tracked here is $1M.
- How many biotech series c investors & vc firms lead rounds?
- 121 of the 623 biotech series c investors & vc firms tracked here lead investment rounds.
Related lists
Series C Investors & VC Firms (2841)Biotech Investors & VC Firms (2169)Biotech Seed Investors & VC Firms (1814)Biotech Series A Investors & VC Firms (1654)Series C Investors & VC Firms in North America (1409)Biotech Investors & VC Firms in North America (1380)Biotech Investors & VC Firms in United States (1257)Series C Investors & VC Firms in United States (1219)Series C Investors & VC Firms in Asia-Pacific (996)Series C Investors & VC Firms in Europe (959)
Data sourced from public filings and firms' own websites — see our methodology.
































.png)





















































.jpeg)



